Tandem Diabetes Care, Inc.
HealthcareNASDAQ:TNDM · NASDAQ Global Market
+$0.80 today
Vol 1.75M · Avg 2.36M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-131.9%
avg 106.5%
ROIC
-11.9%
avg -34.1%
ROA
-23.2%
avg -31.3%
Analysis
ROIC is currently the strongest return metric at -11.9% versus its period average of -34.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
John F. Sheridan | President, Chief Executive Officer & Director | $1.49M | — | 71 | $191,103.00 | 0.28% |
Mark Novara | Executive Vice President & Chief Commercial Officer | $786,758.00 | — | 51 | $48,171.00 | 0.07% |
Leigh A. Vosseller | Executive Vice President, Chief Financial Officer & Treasurer | $764,040.00 | — | 53 | $62,657.00 | 0.09% |
Elizabeth Anne Gasser | Executive Vice President and Chief Strategy & Product Officer | $712,214.00 | — | 50 | $33,109.00 | 0.05% |
Shannon Hansen | Executive Vice President, Chief Legal, Privacy & Compliance Officer and Secretary | $712,171.00 | — | 60 | $29,136.00 | 0.04% |
Susan Morrison | Executive Vice President & Chief Administrative Officer | $697,844.00 | — | 47 | $29,136.00 | 0.04% |
Jean-Claude E. Kyrillos | Executive Vice President & Chief Operating Officer | $538,562.00 | — | 62 | $29,136.00 | 0.04% |
Jordan Pinsker | Chief Medical Officer | — | — | — | — | — |
Tom Fox | Executive VP & Chief Human Resources Officer | — | — | — | — | — |
Christina Sun | Vice President & Corporate Controller | — | — | — | — | — |
Rick A. Carpenter | Executive VP & CTO | — | — | 63 | $26,003.00 | 0.04% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
2
$4,355.97
Net Sentiment
$4,355.97
Net selling
Most Active
Novara Mark David
2 transactions
| Date | Insider | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 17, 2026 | Novara Mark David Direct | Sell | 187 | $23.05 | $4,310.35 | |
| Mar 5, 2026 | Novara Mark David Direct | Sell | 2 | $22.81 | $45.62 |
Analysis
Insiders reported 0 buys worth $0.00 and 2 sells worth $4,355.97 over the last 12 months. That adds up to net selling of $4,355.97. Novara Mark David was the most active insider with 2 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A5 analysts |
| Revenue | N/A | N/A | +208.8% | +23.5% (15yr)9 analysts |
| Net Income | N/A | N/A | N/A | N/A9 analysts |
| EBIT | N/A | N/A | N/A | N/A9 analysts |
Analysis
Recent growth has been strongest in Revenue at +208.8% over three years. Forward estimates point to Revenue at +23.5% (15yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Tango Therapeutics, Inc.
NASDAQ:TNGX
$3.59B
Kodiak Sciences Inc.
NASDAQ:KOD
$1.80B
Septerna, Inc.
NASDAQ:SEPN
$1.62B
Fortrea Holdings Inc.
NASDAQ:FTRE
$1.56B
Nurix Therapeutics, Inc.
NASDAQ:NRIX
$1.47B
UroGen Pharma Ltd.
NASDAQ:URGN
$1.45B
Integra LifeSciences Holdings Corporation
NASDAQ:IART
$1.38B
EyePoint Pharmaceuticals, Inc.
NASDAQ:EYPT
$1.09B
Phathom Pharmaceuticals, Inc.
NASDAQ:PHAT
$827.07M
InMode Ltd.
NASDAQ:INMD
$817.88M
Who manages TNDM?
Tandem Diabetes Care, Inc. (TNDM) lists 11 active executives. The top listed executive is Leigh A. Vosseller, Executive Vice President, Chief Financial Officer & Treasurer.
Are TNDM insiders buying or selling?
Recent insider activity shows net selling of $1.31M.
Explore More
Continue the stock analysis
Jump to another research area for this company.